Mohammed F. El-Yamany

532 total citations
24 papers, 403 citations indexed

About

Mohammed F. El-Yamany is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Mohammed F. El-Yamany has authored 24 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Physiology. Recurrent topics in Mohammed F. El-Yamany's work include Diabetes Treatment and Management (4 papers), Neuroscience and Neuropharmacology Research (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Mohammed F. El-Yamany is often cited by papers focused on Diabetes Treatment and Management (4 papers), Neuroscience and Neuropharmacology Research (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Mohammed F. El-Yamany collaborates with scholars based in Egypt, United Arab Emirates and United States. Mohammed F. El-Yamany's co-authors include Marwa M. Safar, Naglaa Assaf, Hala M. Fawzy, Amany M. Gad, Noha F. Abdelkader, Nada A. Sallam, Heba M. Karam, Laila Ahmed Rashed, Mostafa A. Rabie and Sherif S. Abdel Mageed and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and Toxicology and Applied Pharmacology.

In The Last Decade

Mohammed F. El-Yamany

24 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed F. El-Yamany Egypt 11 139 83 64 45 43 24 403
Nayelli Nájera Mexico 13 166 1.2× 77 0.9× 90 1.4× 43 1.0× 42 1.0× 52 474
Thiago MC Pereira Brazil 8 106 0.8× 84 1.0× 79 1.2× 48 1.1× 49 1.1× 9 406
Cini Mathew John Canada 11 123 0.9× 51 0.6× 67 1.0× 39 0.9× 26 0.6× 16 386
Dawit Zewdu Wondafrash Ethiopia 12 133 1.0× 59 0.7× 74 1.2× 40 0.9× 35 0.8× 17 398
Angelica Ruiz‐Ramírez Mexico 10 144 1.0× 62 0.7× 115 1.8× 29 0.6× 62 1.4× 15 372
Suzan Tabur Türkiye 12 96 0.7× 140 1.7× 53 0.8× 52 1.2× 38 0.9× 36 424
Rania Abdellatif Egypt 13 135 1.0× 128 1.5× 40 0.6× 72 1.6× 55 1.3× 26 526
Entesar F. Amin Egypt 13 155 1.1× 120 1.4× 46 0.7× 73 1.6× 72 1.7× 15 583
Genoveva Durán-Reyes Mexico 11 157 1.1× 85 1.0× 102 1.6× 51 1.1× 38 0.9× 17 461
Linlin Li China 14 223 1.6× 61 0.7× 96 1.5× 36 0.8× 53 1.2× 33 517

Countries citing papers authored by Mohammed F. El-Yamany

Since Specialization
Citations

This map shows the geographic impact of Mohammed F. El-Yamany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed F. El-Yamany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed F. El-Yamany more than expected).

Fields of papers citing papers by Mohammed F. El-Yamany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed F. El-Yamany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed F. El-Yamany. The network helps show where Mohammed F. El-Yamany may publish in the future.

Co-authorship network of co-authors of Mohammed F. El-Yamany

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed F. El-Yamany. A scholar is included among the top collaborators of Mohammed F. El-Yamany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed F. El-Yamany. Mohammed F. El-Yamany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Mageed, Sherif S. Abdel, et al.. (2023). MitoQ alleviates hippocampal damage after cerebral ischemia: The potential role of SIRT6 in regulating mitochondrial dysfunction and neuroinflammation. Life Sciences. 328. 121895–121895. 31 indexed citations
5.
El-Yamany, Mohammed F., et al.. (2023). Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: Role of PINK-1/PARKIN and PI3K/Akt/CREB/BDNF/TrKB axis. International Immunopharmacology. 125(Pt B). 111207–111207. 21 indexed citations
6.
El-Yamany, Mohammed F., et al.. (2022). Upregulation of neuronal progranulin mediates the antinociceptive effect of trimetazidine in paclitaxel-induced peripheral neuropathy: Role of ERK1/2 signaling. Toxicology and Applied Pharmacology. 448. 116096–116096. 8 indexed citations
8.
El-Yamany, Mohammed F., et al.. (2021). Role of pERK1/2-NFκB signaling in the neuroprotective effect of thalidomide against cerebral ischemia reperfusion injury in rats. European Journal of Pharmacology. 895. 173872–173872. 4 indexed citations
10.
El-Yamany, Mohammed F., et al.. (2021). Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1. European Journal of Pharmaceutical Sciences. 170. 106105–106105. 32 indexed citations
11.
El-Yamany, Mohammed F., et al.. (2020). Gamma irradiated protease from Echis pyramidum venom: A promising immunogen to improve viper bites treatment. Toxicon. 188. 108–116. 4 indexed citations
12.
El-Yamany, Mohammed F., et al.. (2020). Rice Bran Extract Protected against LPS-Induced Neuroinflammation in Mice through Targeting PPAR-γ Nuclear Receptor. Molecular Neurobiology. 58(4). 1504–1516. 10 indexed citations
13.
Abdelkader, Noha F., et al.. (2020). Ellagic acid attenuates liver toxicity induced by valproic acid in rats. Journal of Pharmacological Sciences. 143(1). 23–29. 77 indexed citations
14.
Karam, Heba M., et al.. (2019). MitoQ ameliorates testicular damage induced by gamma irradiation in rats: Modulation of mitochondrial apoptosis and steroidogenesis. Life Sciences. 232. 116655–116655. 42 indexed citations
15.
El-Yamany, Mohammed F., et al.. (2019). Amelioration of Early Markers of Diabetic Nephropathy by Linagliptin in Fructose-Streptozotocin-Induced Type 2 Diabetic Rats. ˜The œNephron journals/Nephron journals. 141(4). 273–286. 17 indexed citations
16.
Zaafar, Dalia, et al.. (2019). The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients. Journal of Cardiovascular Pharmacology and Therapeutics. 24(3). 254–261. 12 indexed citations
17.
El-Yamany, Mohammed F., et al.. (2018). Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats. Biomedicine & Pharmacotherapy. 109. 910–920. 60 indexed citations
18.
Fattah, Mai A. Abd El, et al.. (2018). Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice. NeuroToxicology. 67. 245–258. 11 indexed citations
20.
Zaki, Hala F., Hesham A. Salem, & Mohammed F. El-Yamany. (2011). Taurine: A promising agent of therapeutic potential in experimentally-induced arthritis. The Egyptian Rheumatologist. 33(3). 131–137. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026